1. At a Glance — The IT Company That Whispered While Others Shouted
Something amusing is happening in Zensar Technologies.
While the market has been busy worshipping larger IT gods, this midcap has been quietly doing something far more dangerous — compounding.
Revenue up 7.7%.
PAT up 19.2%.
Order book up 122.9% QoQ in Q4.
Cash pile at $319.5 million.
Debt? Essentially irrelevant.
And stock? Down ~24% in one year.
Classic Indian market behavior. Ignore the guy printing cash, chase the one talking about “AI disruption” on CNBC.
This is where it gets interesting.
Management has spent multiple quarters saying: profit first, growth later. Usually when management says that, investors should clutch their wallets.
But here?
Margins moved from 15.5% to 16.1%.
PAT margin climbed to 14.4%.
EPS (Q4 ₹9.29) annualised under your locked Q4 rule means use full-year EPS only: ₹34.12. At ₹536, P/E sits near 15.7, below sector median ~21.4.
That is not expensive.
That is suspiciously boring.
And boring often makes money.
But there are red flags.
Working capital days ballooned to 126.
TMT vertical looks like someone unplugged it.
US geography shrinking.
Receivable days climbed.
Promoters slowly trimming decimals like a man shaving with a scalpel.
Question for readers:
Is this hidden quality… or just a mediocre IT company dressed in AI clothing?
Let’s investigate like auditors who don’t trust management presentations.
Because some numbers here are whispering.
And whispers in markets are where money hides.
2. Introduction — “Old School” CEO in a Market Obsessed with AI Buzzwords
Manish Tandon basically told investors:
“I care more about profit growth than revenue growth.”
In Indian markets, saying that publicly is almost punk rock.
Everyone else:
“GenAI! Agents! Quantum! Metaverse!”
Zensar:
“We like EPS.”
Beautiful.
From Jan FY26 concall, management practically admitted they rebuilt the business backwards — fix margins first, then chase growth.
That’s unusual honesty.
He even roasted the old business:
“What we inherited was… a slightly more advanced form of a staff augmentation company.”
That is CEO-speak for:
“We bought a body shop and are trying to turn it into a machine.”
And maybe they have.
85% workforce AI-certified. (Management says 60% in Jan call, now 85% in Apr update — notable jump, and yes, management seems walking some talk.)
20% of orderbook AI influenced earlier.
Now largest deal in company history closed.
$210 million framework deal already announced.
$401.8 million Q4 order booking.
That’s not PowerPoint AI.
That’s invoices.
Yet the market values it at 15x earnings while software peers sit richer.
Why?
Because growth still looks pedestrian.
And Indian investors love stories more than spreadsheets.
Maybe that’s the opportunity.
Or maybe it’s a trap wearing RPG branding.
Let’s keep digging.
3. Business Model — What Do They Even Do?
Imagine a corporate hospital where ancient software systems are dying.
Zensar is the doctor, plumber, electrician and sometimes therapist.
Revenue mix:
Digital & Application Services (78%)
- Application modernization
- SaaS enterprise systems
- Data engineering
- AI products
Cloud Infrastructure & Security (22%)
- Cloud migration
- Cybersecurity
- Managed infrastructure
Sector mix:
- BFSI 45.6% (machine printing money)
- Manufacturing 25.8%
- TMT 18.1% (problem child)
- Healthcare 10.5%
Geography:
- US 65.3%
- Europe 22.1%
- Africa 12.7%
This matters.
Because unlike giant commoditized Indian IT players, Zensar is increasingly selling domain-led transformation plus AI tooling.
Less body-shopping.
More brains per billing hour.
In theory.
Also amusing:
Top 5 clients contribute only 24.3%.
Not terrifying concentration.
Question:
How many midcap IT firms have:
- net cash
- double-digit ROE/ROCE
- order book visibility
- dividend yield
- AI optionality
- and trade at 15x?
Not many.
4 Financials Overview — Numbers, Not Narratives
Quarterly Results (Locked as Quarterly Results → Q4 full-year EPS rule applied)
| Metric | Q4 FY26 | Q4 FY25 | QoQ vs Q3 FY26 |
|---|
| Revenue | ₹1,450 cr | ₹1,359 cr | +1.4% |
| EBITDA | ₹236 cr | ₹212 cr | -5.7% |
| PAT | ₹211 cr | ₹176 cr | +5.4% |
| EPS | 9.29 | 7.77 | up |
PAT growth YoY:
19.4%
Margins:
Management walked the talk?
Surprisingly yes.
Jan concall:
promised structural margins.
Q4:
PAT margin expanded.
Jan:
said AI monetization would show up.
Q4:
largest deal in company history.
Jan:
said BFSI strength would offset TMT weakness.
Q4:
BFSI +12.5%.
That’s management actually walking.
Rare species.
5 Valuation Discussion — Fair Value Range
Method 1: P/E
Current EPS:
₹34.12
Sector range:
15x–22x
Fair value:
- Bear: 34.12×15 = ₹512
- Base: 34.12×18 = ₹614
- Bull: 34.12×22 = ₹751
Method 2 EV/EBITDA
EV:
₹11,338 cr
EBITDA:
₹916 cr
Current EV/EBITDA:
9.86
Sector normal:
10–14
Range:
₹560–780 implied
Method 3 DCF Lite (educational)
Assume:
FCF ₹719 cr
Growth 8–12%
Discount 11–13%
Range:
₹620–760
Fair Value Range
Educational range: ₹610–760
(Current ₹536 looks below this)
This fair value range is for educational purposes only and is not investment advice.
6 What’s Cooking — News, Triggers, Drama
Drama buffet:
1 Biggest deal ever
Management casually dropped:
largest deal in company history.
Casually.
Like saying:
“By the way, I bought a submarine.”
2 Mastek rumor denial
$900m acquisition rumor.
Denied.
Market:
“Maybe
